Microfluidic 3D hepatic cultures integrated with a droplet-based bioanalysis unit
Biosensors and Bioelectronics · 2024
DOI: 10.1016/j.bios.2023.115896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024. Verfasst von Jose M de Hoyos-Vega und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Microfluidic Analytical Techniques, Biosensing Techniques. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, Mayo Clinic.
Abstract (Originalsprache)
A common challenge in microfluidic cell cultures has to do with analysis of cell function without replacing a significant fraction of the culture volume and disturbing local concentration gradients of signals. To address this challenge, we developed a microfluidic cell culture device with an integrated bioanalysis unit to enable on-chip analysis of picoliter volumes of cell-conditioned media. The culture module consisted of an array of 140 microwells with a diameter of 300 m which were made low-binding to promote organization of cells into 3D spheroids. The bioanalysis module contained a droplet generator unit, 15 micromechanical valves and reservoirs loaded with reagents. Each 0.8 nL droplet contained an aliquot of conditioned media mixed with assay reagents. The use of microvalves allowed us to load enzymatic assay and immunoassay into sequentially generated droplets for detection of glucose and albumin, respectively. As a biological application of the microfluidic device, we evaluated hormonal stimulation and glucose consumption of hepatic spheroids. To mimic physiological processes occurring during feeding and fasting, hepatic spheroids were exposed to pancreatic hormones, insulin or glucagon. The droplet-based bioanalysis module was used to measure uptake or release of glucose upon hormonal stimulation. In the future, we intend to use this microfluidic device to mimic and measure pathophysiological processes associated with hepatic insulin resistance and diabetes in the context of metabolic syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
- Laboratory of Microtechnologies Applied to Biomedicine, Centro de Investigación y de Estudios Avanzados (Cinvestav), Monterrey, NL, Mexico.
- Division of Gastroenterology and Hepatology, Mayo Clinic, MN, USA.
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA. Electronic address: Revzin.Alexander@mayo.edu.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- Mayo Clinic
- National Institutes of Health
Zitieren
APA
de Hoyos-Vega, J. M., Gonzalez-Suarez, A. M., Cedillo-Alcantar, D. F., Stybayeva, G., Matveyenko, A., Malhi, H., Garcia-Cordero, J. L., & Revzin, A. (2024). Microfluidic 3D hepatic cultures integrated with a droplet-based bioanalysis unit. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115896
Vancouver
de Hoyos-Vega JM, Gonzalez-Suarez AM, Cedillo-Alcantar DF, Stybayeva G, Matveyenko A, Malhi H, et al. Microfluidic 3D hepatic cultures integrated with a droplet-based bioanalysis unit. Biosensors and Bioelectronics. 2024. doi:10.1016/j.bios.2023.115896
BibTeX
@article{deHoyosVega2024,
author = {de Hoyos-Vega, Jose M and Gonzalez-Suarez, Alan M and Cedillo-Alcantar, Diana F and Stybayeva, Gulnaz and Matveyenko, Aleksey and Malhi, Harmeet and Garcia-Cordero, Jose L and Revzin, Alexander},
title = {Microfluidic 3D hepatic cultures integrated with a droplet-based bioanalysis unit},
journal = {Biosensors and Bioelectronics},
year = {2024},
doi = {10.1016/j.bios.2023.115896}
}
EUVIMED